Trials / Completed
CompletedNCT01379560
A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Sucampo Pharma Americas, LLC · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the pharmacodynamics of ocular blood flow measurements with multiple drop unoprostone isopropyl administration versus placebo in subjects with dry age-related macular degeneration (AMD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | unoprostone isopropyl | 1. unoprostone isopropyl (2 drops) 2. placebo (2 drops) |
| DRUG | unoprostone isopropyl | 1. unoprostone isopropyl (3 drops) 2. placebo (3 drops) |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2011-06-23
- Last updated
- 2019-12-10
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT01379560. Inclusion in this directory is not an endorsement.